Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xpcos Plus
- Development stage
- Unknown
- Lead developer
- Med Manor Organics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xpcos Plus is an oral fixed-dose combination nutraceutical tablet developed and marketed by Med Manor Organics for the management of polycystic ovary syndrome (PCOS). The formulation contains myo-inositol, D-chiro-inositol, cholecalciferol (Vitamin D3), levomefolate (L-methylfolate), and chromium picolinate. Together, these ingredients work synergistically to improve insulin sensitivity, restore hormonal balance, support ovarian function, and promote regular menstrual cycles. Myo-inositol and D-chiro-inositol act as second messengers in insulin signaling, enhancing glucose uptake and reducing hyperandrogenism. Chromium picolinate further potentiates insulin action, while levomefolate provides the active form of folate to support cellular division and reduce homocysteine levels. Cholecalciferol supports overall metabolic and reproductive health by binding to the vitamin D receptor.
- Brand names
- Xpcos Plus
02
Targets
FOLR1 (FRα)INSR (Insulin receptor)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Xpcos Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xpcos Plus.